BMC Cancer Q1
Unclaimed
BioMed Central Ltd.
United Kingdom
BMC Cancer is a journal indexed in SJR in Genetics and Oncology with an H index of 149. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 1,137 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,137.
BMC Cancer focuses its scope in these topics and keywords: cancer, breast, patients, cell, expression, ovarian, study, human, therapy, lung, ...
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -


Price
2390 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,137
SJR Impact factor149
H Index1345
Total Docs (Last Year)3781
Total Docs (3 years)54333
Total Refs16111
Total Cites (3 years)3780
Citable Docs (3 years)3.72
Cites/Doc (2 years)40.4
Ref/DocOther journals with similar parameters
Genome Biology Q1
Nature Microbiology Q1
Cell Stem Cell Q1
Nucleic Acids Research Q1
Annual Review of Genetics Q1
Compare this journals
Comments